Navigation Links
Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer
Date:9/20/2007

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced today that complete enrollment of its Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma (advanced carcinoid cancer) was accomplished ahead of schedule. The trial, designed to enroll 40 patients, presently has patients enrolled at seven clinical sites in the U.S., and was closed to further enrollment with the addition of the 40th patient.

"This Atiprimod trial was initiated in November, 2006 and we are pleased with the tremendous pace of enrollment that we experienced," said Dr. Gary S. Jacob, Chief Executive Officer of Callisto. "We have patients who have now been on our drug for as long as 11 months, and we expect that by January of 2008 the bulk of patients will have been treated for 6 months or more on our drug. We anticipate at that time releasing interim data from the trial as well as planning for a meeting with FDA on the design of a registration trial."

The primary objective of the Phase II clinical trial was to evaluate efficacy of Atiprimod in patients with low to intermediate grade neuroendocrine carcinoma who have metastatic or unresectable cancer and who have progression of their disease despite standard therapy (octreotide). Patients, after signing an informed consent, were required to complete two weeks of a symptoms diary to establish their symptoms baseline before commencing Atiprimod dosing. Efficacy evaluations include the measure of target lesions (per RECIST), and the quantization of symptom relief. Further details of this trial can be found at http://www.clinicaltrials.gov.

About Atiprimod

Atiprimod is an orally bio-available small molecule drug that displays multiple mechanisms of action. The drug
'/>"/>

SOURCE Callisto Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... May 17, 2013  Serving a region of 650,000 inhabitants ... , Caribbean Imaging and Radiation Therapy (CIRT, Ponce ... with the acquisition of an Elekta Versa HD™ system, the ... offers clinicians the versatility to deliver conventional therapies to treat ... enabling treatment of highly complex cancers that require extreme targeting ...
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3
... Acuo Technologies®, a market leading provider of ... for archiving, collaboration and migration services, announces another ... The company achieved 25% growth over the previous ... growth rate of 55% in revenue, while adding ...
... Today, Siemens (NYSE: SI ) announces ... Medical Informatics Officer (CMIO), of the Health Services (HS) Business ... Health Information Exchange (IHIE), Marc recently served as ... role at Siemens, Marc will be responsible for clinical informatics ...
Cached Medicine Technology:Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position 2Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
(Date:5/19/2013)... According to a May 14th, 2013 Harper’s Bazaar ... about the appearance of certain areas of the body. ... fail to tone and tighten these areas. The report details ... get the firmest body possible (article: goo.gl/tPiha). , ... Simon Ourian, Medical Director of Epione Beverly Hills. “I don’t ...
(Date:5/19/2013)... May 19, 2013 In partnership with the ... has announced the launch of an SEO website for dentists. ... high rankings in Google. , http://www.e-dentists.com/ , A ... for the service until they see results. Dentists can request ... generation websites run by JD Media Surge, LLC rank high ...
(Date:5/19/2013)... May 19, 2013 Grinding your teeth ... losing sleep, or annoying your spouse. At the same ... CNY Central (“Snoring and Teeth Grinding Could Be a ... teeth grinding can be hard to prevent. Apparently, Obstructive ... and one of its symptoms is a habit of ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The report ... Global Trends & Forecasts up to 2017” published by ... market with analysis and forecasting of the global volume ... identifies the driving and restraining factors for the global ... imperatives, and challenges. The market is segmented and revenue ...
(Date:5/19/2013)... Farming methods have changed many times since ... years ago. Most recently, the Green Revolution has transformed ... engineered seeds and by applying chemical fertilizers and pesticides. ... techniques due to the adverse environmental and health effects ... in interest in organic, sustainable farming practices and techniques. ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3
... gender bias prevailing against women, especially when they are required ... that inhibits free-flowing analysis of pros // , while accentuating ... surgery. There has always been an overriding influence of surgery ... club", which also implies possession of the ‘right surgical personality’, ...
... review of recent studies has found that immune-boosting therapies do ... cause for miscarriage is not yet clear, but reserachers believe ... fetus. ,To prevent this from happening, doctors usually ... Porter, M.D., of the LDS Hospital in Salt Lake City ...
... alarming that the actual number of HIV/Aids unreported cases ... 24,000 to 150,000).// ,Of the reported cases, ... 2004 was injecting drug use (73.72 per cent). Close ... have sex with men (4.0 per cent) and mother-to-child ...
... pill used worldwide for inducing labor and preventing post-delivery bleeding ... drugs. Researchers have however urged that the drug must be ... known generically as misoprostol and sold as Cytotec – is ... approved for use in pregnant woman in most countries, including ...
... at conclusive evidence regarding which method is the most ... using mouthwashes, breath mints, chewing gums, sprays or mechanical ... ,'From the results of some low-powered trials, ... some benefit at reducing halitosis, and the effects appear ...
... to a recent study, using computer-based "surgery simulators" will ... surgeries. // It was found that surgeons trained with ... better than their peers in performing an interventional technique ... is scheduled for presentation on Thursday, April 20, 9:35 ...
Cached Medicine News:Health News:Misplaced Bravado: A Career In Surgery Eludes Women? 2Health News:Concerns About Popular Anti-Ulcer Pill Used For Inducing Labor 2Health News:Concerns About Popular Anti-Ulcer Pill Used For Inducing Labor 3Health News:Treating Bad Breath Yet A Challenge 2Health News:Surgery Simulators Offer Better Surgeons And Safer Surgeries 2
Rapid Exchange Stent Delivery System with Hepacoat...
6.5mm diameter handpiece; 75mm handle with grooves for grip; Standard male luer taper fits most cannula hub and female luer taper....
3 Piece with .35mm Angled Point, Curved to Left, #8, Side Opening Irrigation, 40mm overall length; in stainless steel; 30cm Long Silicone Tubing with Connector....
5x6mm Loop, 2 Irrigation Ports at 10, 2 O'Clock, 18 Gauge Thin Walled 1.2mm Shaft; overall length 40mm; stainless steel...
Medicine Products: